Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.2069
-0.0230 (-10.00%)
Apr 1, 2026, 11:12 AM EDT - Market open
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $20.21 million as of April 1, 2026. Its market cap has decreased by -66.44% in one year.
Market Cap
20.21M
Enterprise Value
-1.58M
1-Year Change
-66.44%
Ranking
Category
Stock Price
$0.21
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $20.21M, a decrease of -89.56%. That is a compound annual growth rate of -23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 22.50M | -6.25% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 24.52M |
| Quantum BioPharma | 24.47M |
| ABVC BioPharma | 23.97M |
| Serina Therapeutics | 23.89M |
| Tempest Therapeutics | 23.52M |
| Barinthus Biotherapeutics | 23.24M |
| Vistagen Therapeutics | 22.64M |
| Neuphoria Therapeutics | 22.05M |